Irkec, C. Et Al. 2017. Serum fractalkine levels in patients with vascular dementia, Alzheimer's disease and mild cognitive impairment. 23rd World Congress of Neurology (WCN) , (Kyoto, Japan), 663.

Irkec, C., Kuz, T., Altiparmak, T., & Fidan, I., (2017). Serum fractalkine levels in patients with vascular dementia, Alzheimer's disease and mild cognitive impairment . 23rd World Congress of Neurology (WCN) (pp.663). Kyoto, Japan

Irkec, C. Et Al. "Serum fractalkine levels in patients with vascular dementia, Alzheimer's disease and mild cognitive impairment," 23rd World Congress of Neurology (WCN), Kyoto, Japan, 2017

Irkec, C. Et Al. "Serum fractalkine levels in patients with vascular dementia, Alzheimer's disease and mild cognitive impairment." 23rd World Congress of Neurology (WCN) , Kyoto, Japan, pp.663, 2017

Irkec, C. Et Al. (2017) . "Serum fractalkine levels in patients with vascular dementia, Alzheimer's disease and mild cognitive impairment." 23rd World Congress of Neurology (WCN) , Kyoto, Japan, p.663.

@conferencepaper{conferencepaper, author={C. Irkec Et Al. }, title={Serum fractalkine levels in patients with vascular dementia, Alzheimer's disease and mild cognitive impairment}, congress name={23rd World Congress of Neurology (WCN)}, city={Kyoto}, country={Japan}, year={2017}, pages={663} }